A roughly INR145 million order is material relative to a small-cap manufacturer and signals demand traction in India's distributed solar supply chain. The concurrent rebrand to Regenova Renewtech suggests a strategic repositioning toward renewables identity, though the after-hours dip implies investors wanted scale or margin detail the filing omitted. Execution and module pricing will determine whether this converts to durable earnings.
Gujarat Inject Kerala (BOM:524238) said it has received a purchase order worth about 144.9 million Indian rupees, excluding GST, from Deon Energy, according to a Monday filing.
The order is for the supply of 16,129 solar photovoltaic modules with a capacity of 620 WP each, the filing said.
The company said it is also in the process of changing its name to Regenova Renewtech Ltd.
Shares of the company were down nearly 2% in after-market hours.
The Monetary Authority of Singapore has revised its "single family office" (SFOs) framework to streamline the process for SFOs to establish operations in Singapore, according to a MAS release.An SFO in Singapore is a privately held corporate entity set up by one "ultra-high-net-worth" family to manage assets, investments, and wealth of a single family.The registration protocols have been simplified, effective June 15, with offices required to notify MAS of their operations through a MAS-licensed bank.Annual reporting has been made more straightforward for SFOs, with information on total assets under management and the name of its bank.
Klevo Rewards (ASX:KLV) said it plans to launch a trial of its KLVAUD Australian dollar-backed stablecoin by June 30, according to a Monday filing with the Australian bourse.The company's Fly Wallet subsidiary received legal advice indicating that the stablecoin may qualify as an eligible stablecoin under the current regulatory framework, subject to conditions, per the filing.KLVAUD is planned to be fully backed one-to-one by Australian dollars held in segregated reserve accounts, and aims to support Fly Wallet's broader payments system, the company said.Klevo Rewards shares fell 4% in recent Monday trade.
Bio-Thera Solutions (SHA:688177) received the results of the European Union's inspection of its Yonghe manufacturing facility, according to a Shanghai bourse filing on Monday.The French National Agency for the Safety of Medicines and Health Products conducted an inspection on the site between Feb. 4 and Feb. 12.The European Medicines Agency handed a GMP or good manufacturing practice certificate to the company after the factory's drug substance operations passed regulatory standards. However, the regulator found deficiencies in the deviation management measures for the finished formulation of the drugs.